Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Lundgren

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|November 19, 2021
Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4<sup>+</sup> T-Cell ResponsesEmelie Marklund, Susannah Leach, Kristina Nyström, et al.
Clinical Immunology (Orlando, Fla.)|March 3, 2009
Decreased IgA antibody production in the stomach of gastric adenocarcinoma patientsMarianne Quiding-Järbrink, Patrik Sundström, Anna Lundgren, et al.
Infectious Diseases (London, England)|February 4, 2026
Long-term follow-up of antibody and T-cell responses after COVID-19 mRNA vaccination in infection-naïve and infected individuals with focus on breakthrough infectionsEmelie Marklund, Susannah Leach, Kristina Nyström, et al.
Vaccine|November 13, 2021
Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infantsAnn-Mari Svennerholm, Firdausi Qadri, Anna Lundgren, et al.
Clinical Case Reports|February 28, 2022
Confirmed reinfection with SARS-CoV-2 during a pregnancy: A case reportVerena Sengpiel, Ylva Carlsson, Jan-Åke Liljeqvist, et al.
Lung Cancer (Amsterdam, Netherlands)|October 12, 2025
Coordinated humoral and cellular immune responses to COVID-19 vaccination in non-small cell lung cancer patients treated with immune checkpoint inhibitorsAnna Lundgren, Susannah Leach, Joanna Kaim, et al.
Plos One|April 10, 2014
Th1 and Th17 responses to Helicobacter pylori in Bangladeshi infants, children and adultsTaufiqur R Bhuiyan, M M Towhidul Islam, Taher Uddin, et al.
Vaccine|December 6, 2016
Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic countryMarjahan Akhtar, Firdausi Qadri, Taufiqur R Bhuiyan, et al.
Vaccine|January 21, 2014
Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in BangladeshTaufiqur R Bhuiyan, Feroza K Choudhury, Farhana Khanam, et al.
Frontiers in Oncology|February 27, 2023
Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancerNikita Dutta, Anna Rohlin, Ella A Eklund, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|November 19, 2021
Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4<sup>+</sup> T-Cell ResponsesEmelie Marklund, Susannah Leach, Kristina Nyström, et al.
Clinical Immunology (Orlando, Fla.)|March 3, 2009
Decreased IgA antibody production in the stomach of gastric adenocarcinoma patientsMarianne Quiding-Järbrink, Patrik Sundström, Anna Lundgren, et al.
Infectious Diseases (London, England)|February 4, 2026
Long-term follow-up of antibody and T-cell responses after COVID-19 mRNA vaccination in infection-naïve and infected individuals with focus on breakthrough infectionsEmelie Marklund, Susannah Leach, Kristina Nyström, et al.
Vaccine|November 13, 2021
Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infantsAnn-Mari Svennerholm, Firdausi Qadri, Anna Lundgren, et al.
Clinical Case Reports|February 28, 2022
Confirmed reinfection with SARS-CoV-2 during a pregnancy: A case reportVerena Sengpiel, Ylva Carlsson, Jan-Åke Liljeqvist, et al.
Lung Cancer (Amsterdam, Netherlands)|October 12, 2025
Coordinated humoral and cellular immune responses to COVID-19 vaccination in non-small cell lung cancer patients treated with immune checkpoint inhibitorsAnna Lundgren, Susannah Leach, Joanna Kaim, et al.
Plos One|April 10, 2014
Th1 and Th17 responses to Helicobacter pylori in Bangladeshi infants, children and adultsTaufiqur R Bhuiyan, M M Towhidul Islam, Taher Uddin, et al.
Vaccine|December 6, 2016
Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic countryMarjahan Akhtar, Firdausi Qadri, Taufiqur R Bhuiyan, et al.
Vaccine|January 21, 2014
Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in BangladeshTaufiqur R Bhuiyan, Feroza K Choudhury, Farhana Khanam, et al.
Frontiers in Oncology|February 27, 2023
Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancerNikita Dutta, Anna Rohlin, Ella A Eklund, et al.
Pageof 7